If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
80.78    0.90 (1.13%)
Bid:
80.50
Ask:
80.56
Spread: 0.06 (0.075%)
Market Cap: £2.81b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

23 Apr 2024 07:00

RNS Number : 5884L
Taylor Wimpey PLC
23 April 2024
 

23 April 2024

Taylor Wimpey plc

Trading statement for the period covering 1 January 2024 to today

 

Spring selling season progressing as expected, full year 2024 guidance reiterated

Taylor Wimpey plc is holding its Annual General Meeting (AGM) today at 10:30am at the Crowne Plaza Hotel in Gerrards Cross, where the following comments will be made regarding current trading, financial performance, and outlook for the financial year.

Jennie Daly, Chief Executive commented:

"We have made a good start to 2024 with the Spring selling season progressing as expected. While we are mindful of ongoing market uncertainty and affordability challenges, it is pleasing to see continued market stability supported by good mortgage availability and sustained customer confidence. Our teams are working hard on the ground to support our customers through the buying process, underpinned by our strong marketing strategy and the quality and location of our homes, which are driving good levels of interest.

Looking ahead, we are confident that we have a strong and resilient business supported by a high-quality, well-located landbank. We remain focused on driving value and investing in the long term sustainability of the business, and we remain on track to deliver our guidance for 2024 while ensuring we are positioned for growth from 2025, assuming supportive market conditions."

UK current trading

The Spring selling season is progressing in line with our expectations. Traffic to our website is encouraging and there are good levels of visitors to our sites despite some market uncertainty and affordability challenges for some customers. Lenders continue to be supportive and mortgage rates remain competitive and below last year's highs, with good product availability.

Our net private sales rate for the year to 21 April 2024 was 0.73 per outlet per week (2023: 0.75), with a cancellation rate of 13% (2023: 15%). Excluding bulk sales, our net private sales rate for the year to 21 April 2024 was 0.69 per outlet per week (2023: 0.66).

As at 21 April 2024, our total order book value stood at £2,090 million (2023: £2,379 million) representing 7,686 homes (2023: 8,576 homes).

High-quality landbank

We are differentiated by our high-quality, well-located landbank, which is supported by a strong strategic land pipeline, providing additional optionality through the cycle. We continue to focus on the conversion of plots from our strategic pipeline and successfully converted c.1.5k plots into our short term landbank in the period. We remain selective in our approach to new acquisitions but will be active where we see opportunities that balance risk, reward and returns to create shareholder value. In the year to date we have approved c.1.4k new plots. At the end of March 2024, our short term landbank stood at c.81k plots (2023: c.86k plots), with a further c.140k potential plots (2023: c.140k plots) in our strategic pipeline.

Dividend

As previously announced, we intend to pay a 2023 final ordinary dividend of 4.79 pence per share on 10 May 2024 (2022 final dividend: 4.78 pence per share), subject to shareholder approval at today's AGM. This is in line with our Ordinary Dividend Policy to return c.7.5% of net assets annually, in two equal instalments.

Outlook

We remain focused on prioritising value over volume, building a strong order book and positioning ourselves for growth from 2025, assuming supportive market conditions.

We continue to expect 2024 UK completions (excluding JVs) to be in the range of 9,500 to 10,000, with completions weighted 45% / 55% in favour of the second half of the year. As previously guided, first half operating profit margin* will reflect slightly lower pricing in the order book and build cost inflation embedded in work in progress of around 4%.

Looking ahead, we remain well positioned in an attractive market with significant unmet demand. Our strong landbank and clear strategy enable us to build high-quality homes, create thriving communities and drive value for our stakeholders through the cycle and into the long term.

 

* Operating profit is defined as profit on ordinary activities before financing, exceptional items and tax, after share of results of joint ventures. Operating profit margin is defined as operating profit divided by revenue.

 

Note:

2023 relates to the equivalent trading period, unless stated

 

-Ends-

 

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 8:30am on 23 April 2024. The call will be recorded and streamed live to our website: www.taylorwimpey.co.uk/corporate/investors/results-and-reports

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

 

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

Notes to editors:

 

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 22 regional businesses across the UK. We also have operations in Spain. Our purpose is to deliver great homes and create thriving communities.

 

For further information, please visit the Group's website: www.taylorwimpey.co.uk/corporate

 

Follow our company page on LinkedIn, Taylor Wimpey plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIASFIFFIS
Date   Source Headline
12th Feb 20189:35 amRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSTotal Voting Rights
10th Jan 20184:28 pmRNSDirectorate Change
10th Jan 20189:47 amRNSDirectorate Change
10th Jan 20187:00 amRNSTrading statement for the year ended 31 Dec 2017
9th Jan 20184:56 pmRNSDirector/PDMR Shareholding
2nd Jan 20188:00 amRNSBlock listing Interim Review
2nd Jan 20188:00 amRNSBlock listing Interim Review
2nd Jan 20188:00 amRNSTotal Voting Rights
11th Dec 20172:16 pmRNSDirector/PDMR Shareholding
1st Dec 201710:00 amRNSDirector/PDMR Shareholding
1st Dec 20179:00 amRNSTotal Voting Rights
30th Nov 20173:04 pmRNSHolding(s) in Company
24th Nov 20179:06 amRNSAdditional Listing
13th Nov 20174:00 pmRNSDirector/PDMR Shareholding
13th Nov 20177:00 amRNSTrading statement
9th Nov 20173:50 pmRNSDirector/PDMR Shareholding
1st Nov 20179:00 amRNSTotal Voting Rights
25th Oct 201712:53 pmRNSHolding(s) in Company
10th Oct 201712:41 pmRNSDirector/PDMR Shareholding
5th Oct 20179:31 amRNSDirector/PDMR Shareholding
2nd Oct 20179:00 amRNSTotal Voting Rights
29th Sep 20174:30 pmRNSDirector/PDMR Shareholding
19th Sep 201710:00 amRNSHolding(s) in Company
11th Sep 20172:01 pmRNSDirector/PDMR Shareholding
1st Sep 20179:00 amRNSTotal Voting Rights
30th Aug 20175:21 pmRNSDevelopment land in Central London
9th Aug 201712:55 pmRNSDirector/PDMR Shareholding
1st Aug 201710:25 amRNSTotal Voting Rights
1st Aug 20177:00 amRNSHalf year results for the period ended 2 July 2017
24th Jul 201712:16 pmRNSDirector/PDMR Shareholding
14th Jul 20178:24 amRNSHolding(s) in Company
11th Jul 20172:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20178:59 amRNSBlock listing Interim Review
3rd Jul 20178:59 amRNSBlock listing Interim Review
29th Jun 201711:38 amRNSTotal Voting Rights
12th Jun 20177:32 amRNSHolding(s) in Company
9th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 20179:28 amRNSTotal Voting Rights
25th May 20174:58 pmRNSDirector/PDMR Shareholding
12th May 20172:07 pmRNSDirector/PDMR Shareholding
9th May 201712:38 pmRNSDirector/PDMR Shareholding
2nd May 201710:38 amRNSTotal Voting Rights
28th Apr 201711:53 amRNSDirector/PDMR Shareholding
27th Apr 20173:20 pmRNSResult of AGM
27th Apr 20171:03 pmRNSDirector/PDMR Shareholding
27th Apr 20177:00 amRNSTrading statement
11th Apr 20173:24 pmRNSDirector/PDMR Shareholding
3rd Apr 201710:33 amRNSTotal Voting Rights
27th Mar 20174:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.